High-Efficiency CRISPR/Cas9-Mediated Correction of a Homozygous Mutation in Achromatopsia-Patient-Derived iPSCs
Laura Siles(Instituto de Microcirugía Ocular), Esther Pomares(Instituto de Microcirugía Ocular)
Cited by 8
Related Papers
Efficient correction of ABCA4 variants by CRISPR-Cas9 in hiPSCs derived from Stargardt disease patients
|Molecular Therapy — Nucleic Acids|2023|24
Rescue of the disease-associated phenotype in CRISPR-corrected hiPSCs as a therapeutic approach for inherited retinal dystrophies
|Molecular Therapy — Nucleic Acids|2025|4